
Investigation into abnormal clots in embalmers' corpses reveals concerning findings and lack of response from regulatory authorities.
-
Thomas Havland conducted an international survey on abnormal clots in embalmers’ corpses. • 1:15
-
Findings showed a high prevalence of white fibrous clots in embalmers’ corpses, with some seeing them as early as 2020. • 4:19
-
Results were sent to FDA but no response was received, raising concerns about regulatory oversight. • 6:19
Investigation into reluctance of embalmers to conduct autopsies amid pandemic.
-
Reluctance to address issues related to excess deaths and lack of autopsies. • 6:38
-
Challenges in obtaining engagement from funeral associations worldwide. • 8:10
-
Significant response from embalmers in Pennsylvania to survey on embalming observations. • 9:01
-
Observation of psychological barriers hindering questioning and scientific inquiry. • 11:00
-
Comparison to scientific observation leading to discoveries like Viagra. • 11:18
-
Importance of noticing changes and considering their significance. • 11:52
-
Survey sent to funeral homes in various cities in the UK for research. • 12:11
Investigation into unusual clotting issues observed by embalmers globally.
-
Survey sent to major funeral director associations, including UK’s National Association of Funeral Directors. • 12:20
-
UK’s National Association of Funeral Directors declined to participate in the survey. • 12:26
-
Potential reasons for non-participation include employee mandates and personal cognitive dissonance. • 12:43
-
Comparison made to historical cases like thalidomide to emphasize the importance of scientific observation. • 14:02
-
Importance of correlating observations to understand potential causes of significant health issues. • 16:29
-
Survey conducted with unbiased questions to gather information on clotting observations from embalmers. • 16:52
-
Second round of data collection completed in January, results sent to FDA, CDC, and NIH. • 17:37
Investigation into unusual clots observed by embalmers in recent years.
-
Embalmers were asked about their experience level and number of bodies embalmed per year. • 18:15
-
Most embalmers had over 20 years of experience, indicating their expertise. • 18:50
-
Average number of bodies embalmed per year was 100, with some embalmers handling over 300. • 20:03
-
Embalming process involves injecting embalming fluid to preserve the body and replace blood. • 20:18
-
Popular injection sites include carotid artery in the neck and iliac artery in the pelvis. • 21:23
-
Some embalmers face challenges with white fibrous clots, leading to longer embalming times. • 22:01
-
Majority of embalmers observed large white fibrous clots in corpses embalmed in 2023. • 22:13
-
Alarming statistic with 7 out of 10 embalmers reporting the presence of these clots. • 22:47
Investigation into unusual blood clots observed by embalmers in 2023 raises concerns about potential health risks.
-
80% of American adults took the initial two injections, but only 15% took the latest booster in 2023. • 23:15
-
Approximately 20% of corpses examined by embalmers in 2023 showed large white fibrous clots. • 25:09
-
79% of embalmers reported observing microclotting in corpses, indicating potential health risks. • 28:03
Investigation into unusual blood clot formations in corpses reveals concerning trends.
-
Increased occurrence of coffee ground microclots and grape jelly clots in corpses. • 28:16
-
Concern over potential widespread organ dysfunction due to difficult-to-detect clotting. • 28:57
-
Challenges in clinical detection of clotting despite significant damage implied. • 29:13
-
Embalmer reports indicate a 5x increase in microclot formations since 2019. • 29:27
-
Significant rise in prevalence of grape jelly clots from 30% to 40% post-2019. • 32:21
-
Observation of varying clot types suggests a complex combination of clotting mechanisms. • 33:07
-
Importance of scientific inquiry and research into the observed clotting phenomena. • 33:25
-
Embalmer community emphasizes the need for further investigation into the issue. • 33:34
Investigation into increased blood clots observed by embalmers across different age groups.
-
Embalmers report significant increase in blood clots, cause unknown. • 33:47
-
Scientific community urged to address cause of phenomenon for safety reasons. • 34:01
-
Survey results confirm widespread observation of blood clots by embalmers. • 34:29
-
21% of embalmers observed increased infant deaths in 2023 compared to previous years. • 35:42
-
25% increase in infant deaths reported by embalmers who observed the phenomenon. • 36:24
-
Blood clots observed across all age groups, with significant increase in 36-50 year olds. • 37:36
-
Older age groups show longest bars in increased blood clot observations. • 38:09
Concerns raised about unexplained excess mortality and lack of vigilance in the scientific community.
-
High excess mortality rates observed globally over the past three years. • 38:43
-
Potential link between cholesterol plaque buildup and age groups 36-50 and 60s. • 38:50
-
Call for vigilance and unbiased scientific inquiry to understand and mitigate health issues. • 40:09
-
Concerns raised about unexplained excess deaths and the need for urgent action. • 41:53
-
Urgent call to address the unexplained excess mortality and hold the scientific community accountable. • 42:26
-
Advocacy for transparency and urgency in addressing significant health challenges. • 43:45
-
Immediate sharing of research findings with regulatory bodies and authorities for action. • 43:51
Investigation of unusual clots found by embalmers reveals concerning data and calls for action from regulatory bodies.
-
White fiberous clots remain an issue in 2023, with over 70% of embalmers still observing them. • 45:05
-
Micro clotting has significantly increased, now seen in about 80% of corpses by embalmers. • 45:27
-
Grape jelly clots continue to be a problem, with about 40% of corpses showing them in 2023. • 45:58
-
An increase in infant deaths and overall clotting of all types has been reported by embalmers. • 46:14
-
Data sent to FDA and CDC suggests a need to halt vaccination program for further investigation. • 46:41
-
Analysis of clot characteristics reveals unusual composition with low magnesium, potassium, and iron. • 48:07
-
High levels of calcium and tin in the clots point towards alternative clotting pathways. • 49:34
-
Persistent lack of answers to questions surrounding the clots raises concerns and emphasizes the need for action. • 50:00
Uncovering unusual white fibrous clots in bodies post-covid injections, raising concerns among morticians and researchers.
-
Research highlights embalmers encountering extensive clotting in bodies, never seen before, post-covid injections. • 50:33
-
Autopsy studies reveal Spike proteins attachment to blood vessel walls, indicating potential risks pre and post-death. • 51:04
-
Involves observe rapid formation of white fibrous clots pre-death, leading to strokes and heart attacks. • 51:51
-
Debunking past medical books, white fibrous clots emerge as a new phenomenon since 2020, urging further research. • 52:55
-
The composition of clots includes fibrin, platelets, and additional proteins, suggesting vessel damage triggers coagulation. • 53:47
-
Drawing parallels to military approach, emphasizing the importance of addressing significant findings to prevent adverse outcomes. • 55:08
Call for thorough investigation of unusual clotting in embalmers to prevent potential catastrophic outcomes.
-
Urgent need for FDA, CDC, and NIH to analyze data on embalmers’ clotting issues like aircraft safety protocols. • 55:43
-
Upcoming discussion on microclotting, emphasizing the importance of further research and autopsies. • 56:12
-
Public urged to challenge authorities for answers and ensure thorough investigations to protect public health. • 56:36
-
Negligence suggested in not investigating excess deaths and abnormal findings related to embalmers’ clotting issues. • 57:16
-
Emphasis on pushing for accountability and protection of public interests in the face of uncertainties. • 57:25